Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) are generally avoided in patients who have undergone radiotherapy for the skeleton due to the association of teriparatide with osteosarcomas in animal models [22, 23]. Here, PTH is linked to osteosarcoma.